Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.

Adams I, Christopher J, Williams KP, Sheppard VB.

J Cancer Educ. 2015 Jun;30(2):344-52. doi: 10.1007/s13187-014-0740-9.

2.

Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review.

Sherman KA, Miller SM, Shaw LK, Cavanagh K, Sheinfeld Gorin S.

J Community Genet. 2014 Apr;5(2):89-98. doi: 10.1007/s12687-013-0164-y. Epub 2013 Aug 10.

3.

Attitudes of African Americans toward return of results from exome and whole genome sequencing.

Yu JH, Crouch J, Jamal SM, Tabor HK, Bamshad MJ.

Am J Med Genet A. 2013 May;161A(5):1064-72. doi: 10.1002/ajmg.a.35914.

4.

Balancing personalized medicine and personalized care.

Cornetta K, Brown CG.

Acad Med. 2013 Mar;88(3):309-13. doi: 10.1097/ACM.0b013e3182806345.

5.

Attitudes and practices among internists concerning genetic testing.

Klitzman R, Chung W, Marder K, Shanmugham A, Chin LJ, Stark M, Leu CS, Appelbaum PS.

J Genet Couns. 2013 Feb;22(1):90-100. doi: 10.1007/s10897-012-9504-z. Epub 2012 May 15.

6.

The influence of health care policies and health care system distrust on willingness to undergo genetic testing.

Armstrong K, Putt M, Halbert CH, Grande D, Schwartz JS, Liao K, Marcus N, Demeter MB, Shea J.

Med Care. 2012 May;50(5):381-7. doi: 10.1097/MLR.0b013e31824d748b.

7.

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K.

CA Cancer J Clin. 2011 Sep-Oct;61(5):327-59. doi: 10.3322/caac.20128. Epub 2011 Aug 19. Review.

8.

Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women.

Graves KD, Christopher J, Harrison TM, Peshkin BN, Isaacs C, Sheppard VB.

J Genet Couns. 2011 Dec;20(6):674-89. doi: 10.1007/s10897-011-9396-3. Epub 2011 Aug 6.

9.

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.

Levy DE, Byfield SD, Comstock CB, Garber JE, Syngal S, Crown WH, Shields AE.

Genet Med. 2011 Apr;13(4):349-55. doi: 10.1097/GIM.0b013e3182091ba4.

10.

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.

Metcalfe KA, Fan I, McLaughlin J, Risch HA, Rosen B, Murphy J, Bradley L, Armel S, Sun P, Narod SA.

Gynecol Oncol. 2009 Jan;112(1):68-72. doi: 10.1016/j.ygyno.2008.10.007. Epub 2008 Nov 20.

11.

Social and ethical implications of genomics, race, ethnicity, and health inequities.

Bonham VL, Knerr S.

Semin Oncol Nurs. 2008 Nov;24(4):254-61. doi: 10.1016/j.soncn.2008.08.005.

12.

What women with ovarian cancer think and know about genetic testing.

Lacour RA, Daniels MS, Westin SN, Meyer LA, Burke CC, Burns KA, Kurian S, Webb NF, Pustilnik TB, Lu KH.

Gynecol Oncol. 2008 Oct;111(1):132-6. doi: 10.1016/j.ygyno.2008.06.016. Epub 2008 Aug 6.

Items per page

Supplemental Content

Write to the Help Desk